Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-15-003906
Filing Date
2015-05-13
Accepted
2015-05-13 16:25:52
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2015 a5615010q.htm 10-Q 525844
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 10601
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 10671
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 10800
5 EXHIBIT 32 ex32.htm EX-32 9840
  Complete submission text file 0001214659-15-003906.txt   3184052

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS dara-20150331.xml EX-101.INS 328700
7 EXHIBIT 101.SCH dara-20150331.xsd EX-101.SCH 28272
8 EXHIBIT 101.CAL dara-20150331_cal.xml EX-101.CAL 29321
9 EXHIBIT 101.DEF dara-20150331_def.xml EX-101.DEF 67753
10 EXHIBIT 101.LAB dara-20150331_lab.xml EX-101.LAB 331302
11 EXHIBIT 101.PRE dara-20150331_pre.xml EX-101.PRE 186627
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 (816) 914-7027
DARA BioSciences, Inc. (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23776 | Film No.: 15858752
SIC: 2834 Pharmaceutical Preparations